CARY,
N.C., May 2, 2024 /PRNewswire/ -- Allucent,
a global mid-sized clinical research organization (CRO), received
two CRO Leadership Awards presented by Clinical Leader and
Life Science Connect for the second consecutive year.
Recipients of these awards are determined based on research
conducted by Industry Standard Research (ISR) to identify
CROs that meet or exceed their customers' expectations. This year,
Allucent received awards in the Expertise and Compatibility
categories across Small Pharma and Overall (Big and Small Pharma
combined).
"We're honored to be recognized through the CRO Leadership
Awards for the second consecutive year," said Mark A. Goldberg, M.D., chairman and chief
executive officer of Allucent. "Exactly two years ago this month we
launched under the Allucent brand with a laser focus on helping
small and mid-sized biotech companies solve their toughest
challenges by bringing unsurpassed value and a true partnership
approach. These awards are a testament to our A-team's ability to
deliver on that mission. We look forward to continuing to exceed
expectations as we help sponsors navigate and accelerate their drug
development journeys in the years ahead."
To determine the award winners, 42 contract research
organizations were assessed on more than 20 performance metrics
through ISR's annual CRO Quality Benchmarking survey. Survey
respondents were recruited from biopharmaceutical companies of all
sizes and have decision-making authority at their companies when
working with CROs. Individuals completing the survey evaluated
companies with whom they had outsourced a project in the past 18
months to ensure the data determining the award winners reflect
first-hand experience working with the CROs being evaluated.
About Allucent
Allucent is on a mission to help
bring new therapies to light by solving the distinct challenges of
its biopharma and government clients. Allucent is a global provider
of comprehensive drug development solutions, including consulting,
clinical operations, biometrics, and clinical pharmacology across
various therapeutic areas. With more than 30 years of experience in
over 60 countries, Allucent's individualized partnership
approach provides experience-driven insights and expertise to
assist its clients in successfully navigating the complexities of
delivering novel treatments to patients.
Visit Allucent.com for more information.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/allucent-recognized-with-cro-leadership-awards-for-expertise-and-compatibility-302134854.html
SOURCE Allucent